Sector updates in February

< 1 minute read

Investment firms

  • ARCH Venture Partners raises $3B for biotech start-ups 
  • Earlybird Health raises €173m for health tech companies 
  • Seroba announces the final close of its Fund IV at €123M ($134M) for early-stage life science companies 
  • New VC fund Scion Life Sciences emerges with $310m to create independent, commercial biotechs 
  • ORI Capital has raised $260m for its second life sciences fund that will go toward early-stage biotechs worldwide focused on diagnostics, therapeutics and drug delivery  
  • 406 Ventures raised $265m for Point 406 Ventures V, L.P., the firm’s fifth core fund, to invest in companies focused on healthcare, data + AI, and cybersecurity 
  • Bupa Asia Pacific raises $20m fund for early-stage healthcare start-ups 


  • Kat Lay appointed Global Health Correspondent at The Guardian 
  • Eleanor Hayward has been promoted to Health Editor at The Times  
  • Nicole Wetsman has been appointed Deputy Editor for Events and Special Projects at Endpoints News 
  • Zinovia Fragkiadaki has left her role as Editor at HealthInvestor 
  • Tom Howarth has been appointed Trends Editor at BBC Science Focus  
  • Timothy Revell has been appointed Executive Editor at New Scientist 
  • Lindsey Leake has been appointed Health and Wellness Reporter at Fortune (US) 
  • Giedre Peseckyte has been appointed Health Care Reporter at POLITICO (EU) 
  • Henry Sandercock has been appointed journalist at MoneyWeek  
  • Seb McCarthy has been appointed Editor at Private Equity News